

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to muramyl dipeptide (GO:0032495) | 4.07506450 |
| 2 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.03588905 |
| 3 | response to peptidoglycan (GO:0032494) | 4.01276137 |
| 4 | embryonic process involved in female pregnancy (GO:0060136) | 3.70193814 |
| 5 | pore complex assembly (GO:0046931) | 3.67412667 |
| 6 | low-density lipoprotein particle clearance (GO:0034383) | 3.60165308 |
| 7 | alpha-linolenic acid metabolic process (GO:0036109) | 3.47489428 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.47473314 |
| 9 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.47473314 |
| 10 | regulation of cholesterol homeostasis (GO:2000188) | 3.39890009 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 3.31572137 |
| 12 | intestinal cholesterol absorption (GO:0030299) | 3.30847400 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.30429592 |
| 14 | cysteine metabolic process (GO:0006534) | 3.22746565 |
| 15 | iron ion import (GO:0097286) | 3.19043230 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 3.19012930 |
| 17 | Rap protein signal transduction (GO:0032486) | 3.18739562 |
| 18 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.16831909 |
| 19 | positive regulation of histone deacetylation (GO:0031065) | 3.14052015 |
| 20 | mitotic sister chromatid cohesion (GO:0007064) | 3.12816163 |
| 21 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.09283243 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 3.09076566 |
| 23 | negative regulation of sterol transport (GO:0032372) | 3.09076566 |
| 24 | urea cycle (GO:0000050) | 3.07934358 |
| 25 | urea metabolic process (GO:0019627) | 3.07934358 |
| 26 | regulation of vitamin metabolic process (GO:0030656) | 3.06487144 |
| 27 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.05595564 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.05142835 |
| 29 | regulation of cholesterol storage (GO:0010885) | 3.05076400 |
| 30 | plasma lipoprotein particle clearance (GO:0034381) | 3.04656604 |
| 31 | necroptotic process (GO:0070266) | 3.04398039 |
| 32 | protein-lipid complex assembly (GO:0065005) | 3.03172887 |
| 33 | protein carboxylation (GO:0018214) | 3.02697207 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.02697207 |
| 35 | plasma lipoprotein particle assembly (GO:0034377) | 3.01031029 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 2.98223493 |
| 37 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.98101106 |
| 38 | L-phenylalanine catabolic process (GO:0006559) | 2.98101106 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.92836681 |
| 40 | germinal center formation (GO:0002467) | 2.92031876 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91206210 |
| 42 | regulation of histone H3-K27 methylation (GO:0061085) | 2.88243062 |
| 43 | nuclear pore complex assembly (GO:0051292) | 2.86959156 |
| 44 | NIK/NF-kappaB signaling (GO:0038061) | 2.86792936 |
| 45 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.85214502 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82685679 |
| 47 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.82578246 |
| 48 | L-phenylalanine metabolic process (GO:0006558) | 2.82578246 |
| 49 | negative regulation of fibrinolysis (GO:0051918) | 2.82256827 |
| 50 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.80417431 |
| 51 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.80355726 |
| 52 | cellular response to arsenic-containing substance (GO:0071243) | 2.80172218 |
| 53 | complement activation, alternative pathway (GO:0006957) | 2.79861477 |
| 54 | macrophage activation involved in immune response (GO:0002281) | 2.79187872 |
| 55 | homocysteine metabolic process (GO:0050667) | 2.78586806 |
| 56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.76055283 |
| 57 | sulfur amino acid catabolic process (GO:0000098) | 2.75881060 |
| 58 | intestinal absorption (GO:0050892) | 2.75627624 |
| 59 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.74041441 |
| 60 | T-helper 1 type immune response (GO:0042088) | 2.73425667 |
| 61 | detection of molecule of bacterial origin (GO:0032490) | 2.73141498 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.72776771 |
| 63 | pentose-phosphate shunt (GO:0006098) | 2.72707206 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 2.70042199 |
| 65 | mannose metabolic process (GO:0006013) | 2.69948751 |
| 66 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.69627780 |
| 67 | regulation of triglyceride catabolic process (GO:0010896) | 2.69555130 |
| 68 | lysine catabolic process (GO:0006554) | 2.69139243 |
| 69 | lysine metabolic process (GO:0006553) | 2.69139243 |
| 70 | nuclear pore organization (GO:0006999) | 2.68697932 |
| 71 | hepatocyte apoptotic process (GO:0097284) | 2.66869132 |
| 72 | phospholipid efflux (GO:0033700) | 2.66303845 |
| 73 | growth hormone receptor signaling pathway (GO:0060396) | 2.65776337 |
| 74 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.65774777 |
| 75 | nitrogen cycle metabolic process (GO:0071941) | 2.65164942 |
| 76 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.64560571 |
| 77 | positive regulation of lipid catabolic process (GO:0050996) | 2.64202330 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.63598654 |
| 79 | positive regulation of interleukin-2 production (GO:0032743) | 2.63289847 |
| 80 | glycine metabolic process (GO:0006544) | 2.61806823 |
| 81 | cellular response to ethanol (GO:0071361) | 2.61716277 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 2.60671863 |
| 83 | positive regulation of type 2 immune response (GO:0002830) | 2.60595574 |
| 84 | phospholipid homeostasis (GO:0055091) | 2.60553918 |
| 85 | response to protozoan (GO:0001562) | 2.59508179 |
| 86 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.59280328 |
| 87 | regulation of RNA export from nucleus (GO:0046831) | 2.58691939 |
| 88 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.57962916 |
| 89 | cellular extravasation (GO:0045123) | 2.56940699 |
| 90 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.56683317 |
| 91 | regulation of protein activation cascade (GO:2000257) | 2.55934176 |
| 92 | regulation of chronic inflammatory response (GO:0002676) | 2.55458125 |
| 93 | reverse cholesterol transport (GO:0043691) | 2.55261388 |
| 94 | negative regulation of lipid transport (GO:0032369) | 2.54647466 |
| 95 | aromatic amino acid family catabolic process (GO:0009074) | 2.53336755 |
| 96 | NADPH regeneration (GO:0006740) | 2.52868568 |
| 97 | regulation of translational fidelity (GO:0006450) | 2.52860296 |
| 98 | positive regulation of interferon-beta production (GO:0032728) | 2.52624097 |
| 99 | establishment of endothelial barrier (GO:0061028) | 2.51775862 |
| 100 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.51209398 |
| 101 | regulation of translation in response to stress (GO:0043555) | 2.50628341 |
| 102 | type I interferon signaling pathway (GO:0060337) | 2.50627543 |
| 103 | cellular response to type I interferon (GO:0071357) | 2.50627543 |
| 104 | regulation of gamma-delta T cell activation (GO:0046643) | 2.50412658 |
| 105 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.49352432 |
| 106 | regulation of centriole replication (GO:0046599) | 2.48602764 |
| 107 | response to type I interferon (GO:0034340) | 2.48053953 |
| 108 | histone demethylation (GO:0016577) | 2.47731435 |
| 109 | defense response to protozoan (GO:0042832) | 2.47435693 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.46844410 |
| 111 | kynurenine metabolic process (GO:0070189) | 2.46518019 |
| 112 | valine metabolic process (GO:0006573) | 2.46365478 |
| 113 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.45273763 |
| 114 | T-helper cell differentiation (GO:0042093) | 2.45273763 |
| 115 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.44742452 |
| 116 | regulation of complement activation (GO:0030449) | 2.44674838 |
| 117 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.44648391 |
| 118 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.44410832 |
| 119 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44175239 |
| 120 | modulation by symbiont of host immune response (GO:0052553) | 2.44175239 |
| 121 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44175239 |
| 122 | modulation by symbiont of host defense response (GO:0052031) | 2.44175239 |
| 123 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44175239 |
| 124 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44175239 |
| 125 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.43123712 |
| 126 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.43042219 |
| 127 | regulation of response to interferon-gamma (GO:0060330) | 2.42759715 |
| 128 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.42406105 |
| 129 | lipoprotein metabolic process (GO:0042157) | 2.42169833 |
| 130 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.41850884 |
| 131 | apoptotic cell clearance (GO:0043277) | 2.41571923 |
| 132 | protein localization to endosome (GO:0036010) | 2.39931310 |
| 133 | regulation of immunoglobulin secretion (GO:0051023) | 2.39610874 |
| 134 | response to laminar fluid shear stress (GO:0034616) | 2.39443357 |
| 135 | histone lysine demethylation (GO:0070076) | 2.39335688 |
| 136 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.39324065 |
| 137 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.39218133 |
| 138 | programmed necrotic cell death (GO:0097300) | 2.39188341 |
| 139 | detection of other organism (GO:0098543) | 2.39090848 |
| 140 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.38905541 |
| 141 | leukocyte aggregation (GO:0070486) | 2.38599150 |
| 142 | trophectodermal cell differentiation (GO:0001829) | 2.38297182 |
| 143 | serine family amino acid biosynthetic process (GO:0009070) | 2.37722554 |
| 144 | positive regulation of heat generation (GO:0031652) | 2.37523152 |
| 145 | serine family amino acid catabolic process (GO:0009071) | 2.37449161 |
| 146 | serine family amino acid metabolic process (GO:0009069) | 2.36831225 |
| 147 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.36690299 |
| 148 | tolerance induction (GO:0002507) | 2.36300957 |
| 149 | protein-lipid complex subunit organization (GO:0071825) | 2.36182688 |
| 150 | cholesterol efflux (GO:0033344) | 2.35334221 |
| 151 | sterol homeostasis (GO:0055092) | 2.34738245 |
| 152 | regulation of fever generation (GO:0031620) | 2.34427811 |
| 153 | cholesterol homeostasis (GO:0042632) | 2.34392259 |
| 154 | regulation of interleukin-12 production (GO:0032655) | 2.34085895 |
| 155 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.33795679 |
| 156 | plasma lipoprotein particle remodeling (GO:0034369) | 2.33089423 |
| 157 | protein-lipid complex remodeling (GO:0034368) | 2.33089423 |
| 158 | macromolecular complex remodeling (GO:0034367) | 2.33089423 |
| 159 | necrotic cell death (GO:0070265) | 2.33088010 |
| 160 | dosage compensation (GO:0007549) | 2.32832542 |
| 161 | bile acid biosynthetic process (GO:0006699) | 2.31683669 |
| 162 | regulation of fibrinolysis (GO:0051917) | 2.31308285 |
| 163 | plasma lipoprotein particle organization (GO:0071827) | 2.30380959 |
| 164 | tetrahydrofolate metabolic process (GO:0046653) | 2.30212780 |
| 165 | one-carbon metabolic process (GO:0006730) | 2.30168753 |
| 166 | regulation of T-helper cell differentiation (GO:0045622) | 2.30095758 |
| 167 | histone H3-K36 demethylation (GO:0070544) | 2.29553362 |
| 168 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.28650298 |
| 169 | ethanol oxidation (GO:0006069) | 2.28297811 |
| 170 | positive regulation of p38MAPK cascade (GO:1900745) | 2.27780407 |
| 171 | T cell lineage commitment (GO:0002360) | 2.26629286 |
| 172 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.25696700 |
| 173 | maternal placenta development (GO:0001893) | 2.24677192 |
| 174 | regulation of integrin activation (GO:0033623) | 2.24635788 |
| 175 | positive regulation of interleukin-12 production (GO:0032735) | 2.24426373 |
| 176 | positive regulation of interleukin-6 production (GO:0032755) | 2.24390854 |
| 177 | myeloid dendritic cell differentiation (GO:0043011) | 2.24022094 |
| 178 | positive regulation of lipid storage (GO:0010884) | 2.23717415 |
| 179 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.23640616 |
| 180 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.23484193 |
| 181 | acylglycerol homeostasis (GO:0055090) | 2.23358732 |
| 182 | triglyceride homeostasis (GO:0070328) | 2.23358732 |
| 183 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.22782862 |
| 184 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.22495513 |
| 185 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.22495513 |
| 186 | cellular response to growth hormone stimulus (GO:0071378) | 2.22310289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.36508926 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.22600943 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.54289732 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.50524585 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.20248471 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.14579593 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.91199232 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.75339421 |
| 9 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72432547 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.56067126 |
| 11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.54422619 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.50674351 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.37419188 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34689926 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.27428422 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.15524691 |
| 17 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.08483507 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07856003 |
| 19 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.07087877 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.03873721 |
| 21 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86025878 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.84441905 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.83063168 |
| 24 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.82436782 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.80066158 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74722496 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.74620746 |
| 28 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.72836123 |
| 29 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68620715 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.66865119 |
| 31 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65554487 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62980364 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.62737785 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.62262457 |
| 35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61435560 |
| 36 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.60472910 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59614957 |
| 38 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57759099 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.56335018 |
| 40 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.54600920 |
| 41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.53214234 |
| 42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.52568264 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51348006 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50395741 |
| 45 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.49351901 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.44820366 |
| 47 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.44176147 |
| 48 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.44176147 |
| 49 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42975803 |
| 50 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42830625 |
| 51 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.42608380 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.42504045 |
| 53 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.42074034 |
| 54 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.42033357 |
| 55 | * MYB_26560356_Chip-Seq_TH2_Human | 1.41128049 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.40983310 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40963799 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.40804387 |
| 59 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39291882 |
| 60 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.37876919 |
| 61 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.35624639 |
| 62 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.34106284 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33993229 |
| 64 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32437490 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.30549155 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29241368 |
| 67 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28620374 |
| 68 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.28042980 |
| 69 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27353461 |
| 70 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27277482 |
| 71 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26699010 |
| 72 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.26596075 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26404362 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25538503 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25381102 |
| 76 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24931898 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24821989 |
| 78 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24474509 |
| 79 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.24040760 |
| 80 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23254964 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 1.23127201 |
| 82 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.22791790 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21135578 |
| 84 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20307872 |
| 85 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19605551 |
| 86 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18415449 |
| 87 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.16127950 |
| 88 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.15241370 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.15238878 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14507688 |
| 91 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.14082753 |
| 92 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.10185606 |
| 93 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.09706445 |
| 94 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.08818444 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08014812 |
| 96 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06981257 |
| 97 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06456675 |
| 98 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.05005810 |
| 99 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04063156 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04016349 |
| 101 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02708809 |
| 102 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02321903 |
| 103 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.01990663 |
| 104 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.01100852 |
| 105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00282488 |
| 106 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00279183 |
| 107 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00167038 |
| 108 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99702309 |
| 109 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.99154680 |
| 110 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.98140883 |
| 111 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97895394 |
| 112 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97219883 |
| 113 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.97064904 |
| 114 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.96823454 |
| 115 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96821233 |
| 116 | MAF_26560356_Chip-Seq_TH2_Human | 0.96036132 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95155610 |
| 118 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.95034048 |
| 119 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94187410 |
| 120 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94007409 |
| 121 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.91661748 |
| 122 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90537993 |
| 123 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90448677 |
| 124 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89625828 |
| 125 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.89413072 |
| 126 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88971256 |
| 127 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.88640871 |
| 128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88221051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002009_preneoplasia | 3.92768451 |
| 2 | MP0005360_urolithiasis | 3.75780080 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.51911363 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.14480863 |
| 5 | MP0008057_abnormal_DNA_replication | 3.07750585 |
| 6 | MP0003724_increased_susceptibility_to | 2.66015263 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.64507829 |
| 8 | MP0005365_abnormal_bile_salt | 2.63275528 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.53520404 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.49625145 |
| 11 | MP0009840_abnormal_foam_cell | 2.45992958 |
| 12 | MP0003303_peritoneal_inflammation | 2.32498331 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.19235369 |
| 14 | MP0003252_abnormal_bile_duct | 2.08533149 |
| 15 | MP0005076_abnormal_cell_differentiation | 2.05352624 |
| 16 | MP0005451_abnormal_body_composition | 1.93385433 |
| 17 | MP0010307_abnormal_tumor_latency | 1.89458559 |
| 18 | MP0001666_abnormal_nutrient_absorption | 1.88976961 |
| 19 | MP0005083_abnormal_biliary_tract | 1.88089388 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 1.86002017 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.84775405 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 1.82360032 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.76987913 |
| 24 | MP0003436_decreased_susceptibility_to | 1.74943550 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.73750408 |
| 26 | MP0000609_abnormal_liver_physiology | 1.68400295 |
| 27 | MP0009278_abnormal_bone_marrow | 1.65378640 |
| 28 | MP0004947_skin_inflammation | 1.57638318 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.53937816 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.53830165 |
| 31 | MP0003828_pulmonary_edema | 1.50464776 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.48854283 |
| 33 | MP0005671_abnormal_response_to | 1.42142947 |
| 34 | MP0000685_abnormal_immune_system | 1.39318513 |
| 35 | MP0002166_altered_tumor_susceptibility | 1.38699925 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.38078894 |
| 37 | MP0005023_abnormal_wound_healing | 1.33102306 |
| 38 | MP0009764_decreased_sensitivity_to | 1.31775706 |
| 39 | MP0005310_abnormal_salivary_gland | 1.29864887 |
| 40 | MP0008004_abnormal_stomach_pH | 1.29349185 |
| 41 | MP0001800_abnormal_humoral_immune | 1.28185814 |
| 42 | MP0002877_abnormal_melanocyte_morpholog | 1.27879191 |
| 43 | MP0005464_abnormal_platelet_physiology | 1.24599897 |
| 44 | MP0006054_spinal_hemorrhage | 1.22840569 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.22297502 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.22297502 |
| 47 | MP0002138_abnormal_hepatobiliary_system | 1.21086613 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.19958300 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.17729741 |
| 50 | MP0010155_abnormal_intestine_physiology | 1.17417313 |
| 51 | MP0005387_immune_system_phenotype | 1.16077829 |
| 52 | MP0001790_abnormal_immune_system | 1.16077829 |
| 53 | MP0001851_eye_inflammation | 1.16060234 |
| 54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.13765439 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.13167319 |
| 56 | MP0006082_CNS_inflammation | 1.12945566 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 1.12109841 |
| 58 | MP0004510_myositis | 1.10452950 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.09971228 |
| 60 | MP0003077_abnormal_cell_cycle | 1.09913283 |
| 61 | * MP0000598_abnormal_liver_morphology | 1.08845789 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.08638821 |
| 63 | MP0005058_abnormal_lysosome_morphology | 1.07890371 |
| 64 | MP0005666_abnormal_adipose_tissue | 1.07621952 |
| 65 | MP0010094_abnormal_chromosome_stability | 1.07103164 |
| 66 | MP0002419_abnormal_innate_immunity | 1.06663670 |
| 67 | MP0001873_stomach_inflammation | 1.06292997 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 1.06158638 |
| 69 | MP0008438_abnormal_cutaneous_collagen | 1.04875208 |
| 70 | MP0004233_abnormal_muscle_weight | 1.03575483 |
| 71 | MP0005647_abnormal_sex_gland | 1.02867631 |
| 72 | MP0002006_tumorigenesis | 1.01460991 |
| 73 | MP0005025_abnormal_response_to | 1.01380429 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 0.99877837 |
| 75 | MP0001845_abnormal_inflammatory_respons | 0.99279835 |
| 76 | MP0005000_abnormal_immune_tolerance | 0.99154035 |
| 77 | MP0002398_abnormal_bone_marrow | 0.97518432 |
| 78 | MP0002723_abnormal_immune_serum | 0.97391478 |
| 79 | MP0002405_respiratory_system_inflammati | 0.95946318 |
| 80 | MP0004808_abnormal_hematopoietic_stem | 0.94962833 |
| 81 | MP0009785_altered_susceptibility_to | 0.93612360 |
| 82 | MP0003448_altered_tumor_morphology | 0.92944376 |
| 83 | MP0001533_abnormal_skeleton_physiology | 0.92257853 |
| 84 | MP0008961_abnormal_basal_metabolism | 0.92184815 |
| 85 | MP0008469_abnormal_protein_level | 0.92041015 |
| 86 | MP0002420_abnormal_adaptive_immunity | 0.91232154 |
| 87 | MP0001819_abnormal_immune_cell | 0.90804624 |
| 88 | MP0001849_ear_inflammation | 0.90720986 |
| 89 | MP0009763_increased_sensitivity_to | 0.90641864 |
| 90 | MP0001915_intracranial_hemorrhage | 0.90539842 |
| 91 | MP0005332_abnormal_amino_acid | 0.90354430 |
| 92 | MP0001216_abnormal_epidermal_layer | 0.90100053 |
| 93 | MP0005621_abnormal_cell_physiology | 0.89823279 |
| 94 | MP0002086_abnormal_extraembryonic_tissu | 0.89044362 |
| 95 | MP0000689_abnormal_spleen_morphology | 0.89007565 |
| 96 | MP0003091_abnormal_cell_migration | 0.87682563 |
| 97 | MP0004197_abnormal_fetal_growth/weight/ | 0.87421870 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.87325737 |
| 99 | MP0000490_abnormal_crypts_of | 0.86948473 |
| 100 | MP0002722_abnormal_immune_system | 0.86408109 |
| 101 | MP0009643_abnormal_urine_homeostasis | 0.84707451 |
| 102 | MP0001730_embryonic_growth_arrest | 0.84153022 |
| 103 | MP0009115_abnormal_fat_cell | 0.83569302 |
| 104 | MP0002796_impaired_skin_barrier | 0.83051521 |
| 105 | MP0000716_abnormal_immune_system | 0.82796646 |
| 106 | MP0001853_heart_inflammation | 0.82279091 |
| 107 | MP0010678_abnormal_skin_adnexa | 0.81879718 |
| 108 | MP0003111_abnormal_nucleus_morphology | 0.81096068 |
| 109 | MP0003868_abnormal_feces_composition | 0.80712008 |
| 110 | MP0009333_abnormal_splenocyte_physiolog | 0.80592698 |
| 111 | MP0009053_abnormal_anal_canal | 0.80529119 |
| 112 | MP0005375_adipose_tissue_phenotype | 0.79902737 |
| 113 | MP0005164_abnormal_response_to | 0.79206055 |
| 114 | MP0002396_abnormal_hematopoietic_system | 0.79189964 |
| 115 | MP0000604_amyloidosis | 0.78790544 |
| 116 | * MP0002429_abnormal_blood_cell | 0.77007745 |
| 117 | MP0002019_abnormal_tumor_incidence | 0.76945435 |
| 118 | MP0000858_altered_metastatic_potential | 0.76827194 |
| 119 | MP0003075_altered_response_to | 0.76491895 |
| 120 | MP0002971_abnormal_brown_adipose | 0.76251234 |
| 121 | MP0002254_reproductive_system_inflammat | 0.75930332 |
| 122 | MP0000733_abnormal_muscle_development | 0.75582368 |
| 123 | MP0002060_abnormal_skin_morphology | 0.75495339 |
| 124 | MP0003795_abnormal_bone_structure | 0.74501169 |
| 125 | MP0003763_abnormal_thymus_physiology | 0.74396189 |
| 126 | MP0002088_abnormal_embryonic_growth/wei | 0.73968685 |
| 127 | MP0000350_abnormal_cell_proliferation | 0.73084175 |
| 128 | MP0005408_hypopigmentation | 0.72876456 |
| 129 | MP0003984_embryonic_growth_retardation | 0.72815736 |
| 130 | MP0003943_abnormal_hepatobiliary_system | 0.69408856 |
| 131 | MP0001727_abnormal_embryo_implantation | 0.68831740 |
| 132 | MP0004782_abnormal_surfactant_physiolog | 0.67484307 |
| 133 | MP0008007_abnormal_cellular_replicative | 0.65492450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 3.84378690 |
| 2 | Xanthomatosis (HP:0000991) | 3.48046817 |
| 3 | Stomatitis (HP:0010280) | 3.39852998 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 3.36021441 |
| 5 | Optic neuritis (HP:0100653) | 3.36021441 |
| 6 | Myocardial infarction (HP:0001658) | 3.30819759 |
| 7 | Intrahepatic cholestasis (HP:0001406) | 3.27074909 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.16106009 |
| 9 | Orchitis (HP:0100796) | 3.14719394 |
| 10 | Hypobetalipoproteinemia (HP:0003563) | 2.93154730 |
| 11 | Acanthocytosis (HP:0001927) | 2.90607965 |
| 12 | Abnormality of the nasal septum (HP:0000419) | 2.88476153 |
| 13 | Spastic diplegia (HP:0001264) | 2.82097628 |
| 14 | Sparse lateral eyebrow (HP:0005338) | 2.77701945 |
| 15 | Complement deficiency (HP:0004431) | 2.76343143 |
| 16 | Deep philtrum (HP:0002002) | 2.74367611 |
| 17 | Recurrent abscess formation (HP:0002722) | 2.73215819 |
| 18 | Myositis (HP:0100614) | 2.68097678 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 2.67527835 |
| 20 | Autoimmune hemolytic anemia (HP:0001890) | 2.63003100 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.58726043 |
| 22 | Absent frontal sinuses (HP:0002688) | 2.58354516 |
| 23 | Increased mean platelet volume (HP:0011877) | 2.58320559 |
| 24 | Fatigue (HP:0012378) | 2.55131202 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.54899094 |
| 26 | Poikilocytosis (HP:0004447) | 2.54114764 |
| 27 | Epidermoid cyst (HP:0200040) | 2.53870213 |
| 28 | Abnormality of macrophages (HP:0004311) | 2.53532361 |
| 29 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.52960944 |
| 30 | Abnormal platelet volume (HP:0011876) | 2.52491968 |
| 31 | Esophageal varix (HP:0002040) | 2.52174767 |
| 32 | Autoimmune thrombocytopenia (HP:0001973) | 2.51433572 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 2.51347643 |
| 34 | Spinal cord lesions (HP:0100561) | 2.50611311 |
| 35 | Syringomyelia (HP:0003396) | 2.50611311 |
| 36 | Eczematoid dermatitis (HP:0000976) | 2.49982569 |
| 37 | Keratoconjunctivitis sicca (HP:0001097) | 2.48432819 |
| 38 | Acute myeloid leukemia (HP:0004808) | 2.48232402 |
| 39 | Osteolytic defects of the hand bones (HP:0009699) | 2.47849482 |
| 40 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.47849482 |
| 41 | Asymmetry of the thorax (HP:0001555) | 2.47324414 |
| 42 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.39027201 |
| 43 | Hypolipoproteinemia (HP:0010981) | 2.38206229 |
| 44 | Cutaneous melanoma (HP:0012056) | 2.37762678 |
| 45 | Curly hair (HP:0002212) | 2.34316120 |
| 46 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.34177852 |
| 47 | Abnormality of complement system (HP:0005339) | 2.32886448 |
| 48 | Cerebral aneurysm (HP:0004944) | 2.31127166 |
| 49 | Ulnar bowing (HP:0003031) | 2.29914011 |
| 50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.26854011 |
| 51 | Hyperlipoproteinemia (HP:0010980) | 2.25549584 |
| 52 | Reticulocytosis (HP:0001923) | 2.25387638 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.24839651 |
| 54 | Hematochezia (HP:0002573) | 2.24115278 |
| 55 | Keratoconjunctivitis (HP:0001096) | 2.23683409 |
| 56 | Recurrent viral infections (HP:0004429) | 2.22038433 |
| 57 | Viral hepatitis (HP:0006562) | 2.20011441 |
| 58 | Loss of speech (HP:0002371) | 2.19126848 |
| 59 | Thickened calvaria (HP:0002684) | 2.18336520 |
| 60 | Pseudobulbar signs (HP:0002200) | 2.17554942 |
| 61 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.17486789 |
| 62 | Hypoalphalipoproteinemia (HP:0003233) | 2.17200582 |
| 63 | Dysmetric saccades (HP:0000641) | 2.17040862 |
| 64 | Hypochromic microcytic anemia (HP:0004840) | 2.16872689 |
| 65 | Gingival bleeding (HP:0000225) | 2.16392714 |
| 66 | Polycythemia (HP:0001901) | 2.15440428 |
| 67 | Prominent nose (HP:0000448) | 2.15353440 |
| 68 | IgA deficiency (HP:0002720) | 2.14847055 |
| 69 | Slow saccadic eye movements (HP:0000514) | 2.13362449 |
| 70 | Arterial thrombosis (HP:0004420) | 2.13350326 |
| 71 | Relative macrocephaly (HP:0004482) | 2.13080047 |
| 72 | Micronodular cirrhosis (HP:0001413) | 2.12973154 |
| 73 | Joint hemorrhage (HP:0005261) | 2.12548777 |
| 74 | Pustule (HP:0200039) | 2.12476937 |
| 75 | Vasculitis (HP:0002633) | 2.12280712 |
| 76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.11901158 |
| 77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.11901158 |
| 78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.11901158 |
| 79 | Peritonitis (HP:0002586) | 2.11239891 |
| 80 | Hepatitis (HP:0012115) | 2.11009293 |
| 81 | Subacute progressive viral hepatitis (HP:0006572) | 2.10152460 |
| 82 | Entropion (HP:0000621) | 2.08780864 |
| 83 | Hemorrhage of the eye (HP:0011885) | 2.07070016 |
| 84 | Hypercholesterolemia (HP:0003124) | 2.05422601 |
| 85 | Ectropion (HP:0000656) | 2.04811953 |
| 86 | Heterotopia (HP:0002282) | 2.02760268 |
| 87 | Fat malabsorption (HP:0002630) | 1.99548055 |
| 88 | Systemic lupus erythematosus (HP:0002725) | 1.99497903 |
| 89 | Cellulitis (HP:0100658) | 1.95268854 |
| 90 | Tetraparesis (HP:0002273) | 1.94649390 |
| 91 | Short chin (HP:0000331) | 1.92387608 |
| 92 | Blepharitis (HP:0000498) | 1.92028897 |
| 93 | Spontaneous hematomas (HP:0007420) | 1.90869616 |
| 94 | Back pain (HP:0003418) | 1.90698584 |
| 95 | Mitral valve prolapse (HP:0001634) | 1.90664068 |
| 96 | Recurrent fungal infections (HP:0002841) | 1.89897118 |
| 97 | Abnormality of proline metabolism (HP:0010907) | 1.89562307 |
| 98 | Hydroxyprolinuria (HP:0003080) | 1.89562307 |
| 99 | T lymphocytopenia (HP:0005403) | 1.89413796 |
| 100 | Prolonged partial thromboplastin time (HP:0003645) | 1.89055050 |
| 101 | Cortical dysplasia (HP:0002539) | 1.89017895 |
| 102 | Abnormality of the frontal sinuses (HP:0002687) | 1.88693418 |
| 103 | Abnormality of the fingertips (HP:0001211) | 1.88592047 |
| 104 | Abnormality of iron homeostasis (HP:0011031) | 1.88465301 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87714804 |
| 106 | Hand muscle atrophy (HP:0009130) | 1.87685467 |
| 107 | Overlapping toe (HP:0001845) | 1.86730262 |
| 108 | Abnormality of the right ventricle (HP:0001707) | 1.83551810 |
| 109 | Macroorchidism (HP:0000053) | 1.83537181 |
| 110 | Gangrene (HP:0100758) | 1.82822355 |
| 111 | Hyperammonemia (HP:0001987) | 1.82217123 |
| 112 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81438803 |
| 113 | Spondylolisthesis (HP:0003302) | 1.80582592 |
| 114 | Impaired platelet aggregation (HP:0003540) | 1.80407232 |
| 115 | Abnormal platelet function (HP:0011869) | 1.80407232 |
| 116 | Lip pit (HP:0100267) | 1.80053751 |
| 117 | Low anterior hairline (HP:0000294) | 1.79976263 |
| 118 | Abnormality of T cell number (HP:0011839) | 1.79357607 |
| 119 | Gastrointestinal stroma tumor (HP:0100723) | 1.79068771 |
| 120 | Aortic aneurysm (HP:0004942) | 1.78178622 |
| 121 | Prostate neoplasm (HP:0100787) | 1.77599501 |
| 122 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77354266 |
| 123 | Osteomyelitis (HP:0002754) | 1.77086474 |
| 124 | Aplasia cutis congenita (HP:0001057) | 1.76518626 |
| 125 | Increased CSF protein (HP:0002922) | 1.76304458 |
| 126 | Keratitis (HP:0000491) | 1.76279114 |
| 127 | Periodontitis (HP:0000704) | 1.75384814 |
| 128 | Abnormality of the lumbar spine (HP:0100712) | 1.74933709 |
| 129 | Recurrent skin infections (HP:0001581) | 1.74665886 |
| 130 | Hypoglycemic coma (HP:0001325) | 1.74037086 |
| 131 | Colitis (HP:0002583) | 1.73570213 |
| 132 | Upper limb amyotrophy (HP:0009129) | 1.73152227 |
| 133 | Distal upper limb amyotrophy (HP:0007149) | 1.73152227 |
| 134 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.73141910 |
| 135 | Increased cerebral lipofuscin (HP:0011813) | 1.72720394 |
| 136 | Increased IgE level (HP:0003212) | 1.72279645 |
| 137 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.72008275 |
| 138 | Coarse hair (HP:0002208) | 1.71336144 |
| 139 | Abnormality of the intrinsic pathway (HP:0010989) | 1.71064257 |
| 140 | Increased density of long bones (HP:0006392) | 1.70479414 |
| 141 | Abnormal cartilage morphology (HP:0002763) | 1.70285016 |
| 142 | Aneurysm (HP:0002617) | 1.70101552 |
| 143 | Disinhibition (HP:0000734) | 1.70038977 |
| 144 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.69673892 |
| 145 | Increased serum ferritin (HP:0003281) | 1.69598152 |
| 146 | Gastrointestinal infarctions (HP:0005244) | 1.69423446 |
| 147 | Pulmonary infiltrates (HP:0002113) | 1.69384625 |
| 148 | Cutis marmorata (HP:0000965) | 1.68999591 |
| 149 | Recurrent cutaneous fungal infections (HP:0011370) | 1.68655295 |
| 150 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.68655295 |
| 151 | Abnormal foot bone ossification (HP:0010675) | 1.68560731 |
| 152 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.68000980 |
| 153 | Hemoptysis (HP:0002105) | 1.67770731 |
| 154 | Interstitial pulmonary disease (HP:0006530) | 1.67689273 |
| 155 | Disproportionate tall stature (HP:0001519) | 1.67620106 |
| 156 | Mitral stenosis (HP:0001718) | 1.67146947 |
| 157 | Somatic mutation (HP:0001428) | 1.66156171 |
| 158 | Meningitis (HP:0001287) | 1.65401610 |
| 159 | Deviation of the thumb (HP:0009603) | 1.65396828 |
| 160 | Papillary thyroid carcinoma (HP:0002895) | 1.65310994 |
| 161 | Recurrent bacterial skin infections (HP:0005406) | 1.64850537 |
| 162 | Submucous cleft hard palate (HP:0000176) | 1.64238855 |
| 163 | Personality changes (HP:0000751) | 1.63633621 |
| 164 | Lymphopenia (HP:0001888) | 1.63320098 |
| 165 | Abnormality of T cell physiology (HP:0011840) | 1.63198514 |
| 166 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.63096221 |
| 167 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.62535268 |
| 168 | Squamous cell carcinoma (HP:0002860) | 1.62511782 |
| 169 | Gingivitis (HP:0000230) | 1.62439607 |
| 170 | Conjugated hyperbilirubinemia (HP:0002908) | 1.61894556 |
| 171 | Urticaria (HP:0001025) | 1.61862278 |
| 172 | Menorrhagia (HP:0000132) | 1.61659119 |
| 173 | Conjunctival telangiectasia (HP:0000524) | 1.61007540 |
| 174 | Thrombophlebitis (HP:0004418) | 1.60890991 |
| 175 | Progressive sensorineural hearing impairment (HP:0000408) | 1.60608953 |
| 176 | Thin bony cortex (HP:0002753) | 1.59353464 |
| 177 | Papilloma (HP:0012740) | 1.58827459 |
| 178 | Verrucae (HP:0200043) | 1.58827459 |
| 179 | Metaphyseal cupping (HP:0003021) | 1.58535155 |
| 180 | Nephritis (HP:0000123) | 1.57339065 |
| 181 | Abnormality of nucleobase metabolism (HP:0010932) | 1.57337130 |
| 182 | Hyperacusis (HP:0010780) | 1.56697527 |
| 183 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.56300806 |
| 184 | Abnormality of glycine metabolism (HP:0010895) | 1.56300806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 3.78111461 |
| 2 | TRIB3 | 3.37324519 |
| 3 | PKN2 | 3.28269311 |
| 4 | PRPF4B | 3.17672136 |
| 5 | EEF2K | 3.07212280 |
| 6 | MAP3K10 | 2.97432897 |
| 7 | CDK12 | 2.88215362 |
| 8 | ERN1 | 2.83328748 |
| 9 | IRAK3 | 2.77168919 |
| 10 | SIK3 | 2.36638606 |
| 11 | MAP4K1 | 2.24575869 |
| 12 | STK10 | 2.17908379 |
| 13 | AKT3 | 2.14809745 |
| 14 | FGFR4 | 2.09401395 |
| 15 | BMPR2 | 2.07233033 |
| 16 | SIK1 | 2.05113578 |
| 17 | EPHB1 | 2.01676425 |
| 18 | PTK6 | 1.98066544 |
| 19 | RIPK1 | 1.78009871 |
| 20 | TYK2 | 1.77744867 |
| 21 | IRAK4 | 1.75551065 |
| 22 | EIF2AK3 | 1.70354147 |
| 23 | LATS1 | 1.68650123 |
| 24 | SCYL2 | 1.65389049 |
| 25 | NEK6 | 1.61798400 |
| 26 | CAMK1D | 1.59513541 |
| 27 | GRK6 | 1.59034882 |
| 28 | YES1 | 1.58335386 |
| 29 | CDK6 | 1.56578677 |
| 30 | LRRK2 | 1.55074404 |
| 31 | RIPK4 | 1.52122005 |
| 32 | TAOK3 | 1.49022899 |
| 33 | IRAK1 | 1.43143671 |
| 34 | BMX | 1.38060282 |
| 35 | TAOK2 | 1.35460144 |
| 36 | JAK1 | 1.34731809 |
| 37 | IRAK2 | 1.34717592 |
| 38 | STK3 | 1.30323882 |
| 39 | NEK2 | 1.28753603 |
| 40 | FGFR3 | 1.26571672 |
| 41 | CSK | 1.26455489 |
| 42 | TBK1 | 1.26014277 |
| 43 | JAK3 | 1.23325304 |
| 44 | FLT3 | 1.21102579 |
| 45 | CDK4 | 1.17991539 |
| 46 | PIM1 | 1.15312040 |
| 47 | MTOR | 1.13485177 |
| 48 | MST1R | 1.11852166 |
| 49 | ALK | 1.11301852 |
| 50 | BRSK2 | 1.11236166 |
| 51 | MAP3K8 | 1.06957771 |
| 52 | TTN | 1.04671020 |
| 53 | RPS6KA4 | 1.04458493 |
| 54 | JAK2 | 1.03924470 |
| 55 | TGFBR2 | 1.03577431 |
| 56 | FRK | 1.02691437 |
| 57 | PDGFRA | 1.01005289 |
| 58 | MAP3K13 | 1.00899300 |
| 59 | STK4 | 1.00858951 |
| 60 | CAMK1G | 0.99009744 |
| 61 | RPS6KB2 | 0.98143229 |
| 62 | SMG1 | 0.97901991 |
| 63 | MAP3K14 | 0.95749218 |
| 64 | ACVR1B | 0.93498709 |
| 65 | EPHA2 | 0.92995243 |
| 66 | TXK | 0.92003115 |
| 67 | MET | 0.91572540 |
| 68 | ZAP70 | 0.90680807 |
| 69 | MAP3K3 | 0.89196428 |
| 70 | PDGFRB | 0.89066788 |
| 71 | EIF2AK1 | 0.88950753 |
| 72 | ITK | 0.87439506 |
| 73 | PAK2 | 0.86337636 |
| 74 | RAF1 | 0.83510727 |
| 75 | PIM2 | 0.82214985 |
| 76 | DYRK1B | 0.80171079 |
| 77 | CDC7 | 0.79868956 |
| 78 | MAP2K3 | 0.79676953 |
| 79 | BRD4 | 0.78641904 |
| 80 | CSF1R | 0.78550924 |
| 81 | MKNK1 | 0.78461683 |
| 82 | EPHA3 | 0.78247974 |
| 83 | TRPM7 | 0.78088566 |
| 84 | MKNK2 | 0.77013864 |
| 85 | BLK | 0.74002780 |
| 86 | CHUK | 0.73474780 |
| 87 | HCK | 0.71599871 |
| 88 | MAPK11 | 0.71346681 |
| 89 | HIPK2 | 0.70648498 |
| 90 | EIF2AK2 | 0.70357068 |
| 91 | BTK | 0.69423534 |
| 92 | NLK | 0.68115759 |
| 93 | CDK9 | 0.67639794 |
| 94 | MELK | 0.67468751 |
| 95 | PTK2 | 0.67173150 |
| 96 | TSSK6 | 0.66048458 |
| 97 | MAPK12 | 0.65283620 |
| 98 | PDPK1 | 0.65123671 |
| 99 | MARK3 | 0.64743017 |
| 100 | IKBKB | 0.63953155 |
| 101 | GSK3A | 0.63927411 |
| 102 | PAK4 | 0.62715644 |
| 103 | IKBKE | 0.62428628 |
| 104 | MAPK7 | 0.59952576 |
| 105 | RET | 0.59885809 |
| 106 | MATK | 0.59450995 |
| 107 | NEK9 | 0.59132164 |
| 108 | WEE1 | 0.58866599 |
| 109 | MAP3K2 | 0.55952679 |
| 110 | ICK | 0.55761521 |
| 111 | TESK2 | 0.55515921 |
| 112 | ERBB3 | 0.55095999 |
| 113 | DDR2 | 0.54834530 |
| 114 | GRK7 | 0.54137022 |
| 115 | MAP3K1 | 0.53656514 |
| 116 | BCKDK | 0.51950556 |
| 117 | EGFR | 0.51859987 |
| 118 | LATS2 | 0.51616593 |
| 119 | ERBB4 | 0.49460723 |
| 120 | MAP3K7 | 0.49186382 |
| 121 | FGFR2 | 0.48718062 |
| 122 | LCK | 0.48466909 |
| 123 | PRKAA2 | 0.48049756 |
| 124 | CLK1 | 0.47475948 |
| 125 | FGFR1 | 0.47259215 |
| 126 | CDK3 | 0.45361978 |
| 127 | MAP2K2 | 0.43727951 |
| 128 | KSR2 | 0.43689974 |
| 129 | KSR1 | 0.43043009 |
| 130 | LYN | 0.42408631 |
| 131 | RPS6KB1 | 0.42014925 |
| 132 | ABL1 | 0.41825359 |
| 133 | FGR | 0.41683045 |
| 134 | TTK | 0.40549183 |
| 135 | CHEK1 | 0.39882447 |
| 136 | MAPK3 | 0.37853068 |
| 137 | MST4 | 0.37715341 |
| 138 | RPS6KA1 | 0.36586797 |
| 139 | TAOK1 | 0.36336364 |
| 140 | PDK1 | 0.33818892 |
| 141 | SGK3 | 0.33368003 |
| 142 | SYK | 0.33354632 |
| 143 | AURKB | 0.32933340 |
| 144 | CSNK1D | 0.32667956 |
| 145 | INSR | 0.32562614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.20171834 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.46062526 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.39907283 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.03928622 |
| 5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.03568803 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.01819763 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.93357759 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.85411422 |
| 9 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.69291257 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.68390048 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67646197 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.57880487 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.54856473 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.53395298 |
| 15 | Lysine degradation_Homo sapiens_hsa00310 | 1.53205455 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.51462538 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.45392348 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 1.41882473 |
| 19 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38917770 |
| 20 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.37053209 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36331103 |
| 22 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.34613197 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32272439 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28731028 |
| 25 | Prostate cancer_Homo sapiens_hsa05215 | 1.28133368 |
| 26 | Allograft rejection_Homo sapiens_hsa05330 | 1.20835716 |
| 27 | ABC transporters_Homo sapiens_hsa02010 | 1.20061737 |
| 28 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.16825385 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.15071419 |
| 30 | Leishmaniasis_Homo sapiens_hsa05140 | 1.12545956 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12196304 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11777794 |
| 33 | Endometrial cancer_Homo sapiens_hsa05213 | 1.11304022 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.11268952 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.10355472 |
| 36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10207563 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.09556223 |
| 38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.09125420 |
| 39 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.08870911 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.08364759 |
| 41 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.07025466 |
| 42 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.05351609 |
| 43 | Insulin resistance_Homo sapiens_hsa04931 | 1.04937629 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02274142 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01132813 |
| 46 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99103210 |
| 47 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.97367131 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 0.97114987 |
| 49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96922054 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.94398706 |
| 51 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94024462 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93865169 |
| 53 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.93511155 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.92704749 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91421387 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91313072 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91153091 |
| 58 | Thyroid cancer_Homo sapiens_hsa05216 | 0.90442815 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90304010 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89369102 |
| 61 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89368752 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89315269 |
| 63 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88991135 |
| 64 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88514314 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.88378646 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.87704136 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 0.87417456 |
| 68 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86550594 |
| 69 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85510983 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85095505 |
| 71 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83947710 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83424826 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83012980 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82887363 |
| 75 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82876360 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.82786528 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82511729 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81709228 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.81406495 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81220656 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81189384 |
| 82 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81168605 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.80554233 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80476147 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.79447509 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77787647 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.77359524 |
| 88 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77332172 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75779954 |
| 90 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.75661033 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74652415 |
| 92 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74183087 |
| 93 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73435951 |
| 94 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.73263110 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.72308828 |
| 96 | Shigellosis_Homo sapiens_hsa05131 | 0.71975876 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71700736 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.71505571 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71445395 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71291731 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.70085722 |
| 102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.69874039 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.69509229 |
| 104 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.68510368 |
| 105 | Carbon metabolism_Homo sapiens_hsa01200 | 0.68409927 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.68309364 |
| 107 | Salmonella infection_Homo sapiens_hsa05132 | 0.68248206 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.67814108 |
| 109 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.67323393 |
| 110 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67158128 |
| 111 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.66722067 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.66619042 |
| 113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66502964 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65847783 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65623724 |
| 116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.64309222 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63841758 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63506371 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62712987 |
| 120 | Cell cycle_Homo sapiens_hsa04110 | 0.61994063 |
| 121 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61904326 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.61686682 |
| 123 | Glioma_Homo sapiens_hsa05214 | 0.61062776 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60035110 |
| 125 | Malaria_Homo sapiens_hsa05144 | 0.59255718 |
| 126 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58722252 |
| 127 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.58528337 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57491495 |
| 129 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57198218 |
| 130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.56891879 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.56662501 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56537892 |
| 133 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.56417278 |
| 134 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56000866 |
| 135 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.55852460 |
| 136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.54593917 |
| 137 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54476008 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.54400318 |
| 139 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.54317603 |
| 140 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.54268044 |
| 141 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53967860 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52411863 |
| 143 | Adherens junction_Homo sapiens_hsa04520 | 0.52368440 |
| 144 | Retinol metabolism_Homo sapiens_hsa00830 | 0.51614048 |
| 145 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51398669 |
| 146 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51330048 |
| 147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50864086 |
| 148 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50213736 |
| 149 | RNA transport_Homo sapiens_hsa03013 | 0.50097977 |
| 150 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50087170 |
| 151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47857743 |
| 152 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46106937 |

